Zhoumeng Lin & Jeffrey W. Fisher. 2020. Physiologically Based Pharmacokinetic (PBPK) Modeling. Physiologically Based Pharmacokinetic (PBPK) Modeling
1
26
.
Joachim D. Pleil. (2016) Breath biomarkers in toxicology. Archives of Toxicology 90:11, pages 2669-2682.
Crossref
Harvey III, Jeffry Schroeter & Melvin Andersen. 2014. Inhalation Toxicology, Third Edition. Inhalation Toxicology, Third Edition
147
172
.
Geoff Lockwood. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology
385
396
.
J. Gerald Kenna. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
403
422
.
Dennis J. Paustenbach. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene
957
1046
.
J Kenna. 2007. Drug-Induced Liver Disease, Second Edition. Drug-Induced Liver Disease, Second Edition
465
484
.
Hilmi Orhan. (2007) Analyses of representative biomarkers of exposure and effect by chromatographic, mass spectrometric, and nuclear magnetic resonance techniques: Method development and application in life sciences. Journal of Separation Science 30:2, pages 149-174.
Crossref
Melvin E Andersen. (2003) Toxicokinetic modeling and its applications in chemical risk assessment. Toxicology Letters 138:1-2, pages 9-27.
Crossref
Dennis J. Paustenbach. 2001. Patty's Industrial Hygiene. Patty's Industrial Hygiene.
P. M. Vermeulen, J. G. C. Lerou, R. Dirksen, L. H. D. J. Booij & G. F. Borm. (1995) A System Model for Halothane Closed-Circuit Anesthesia. Anesthesiology 83:3, pages 515-527.
Crossref
Martin D. Barratt, Jose V. Castell, Mark Chamberlain, Robert D. Combes, John C. Dearden, Julia H. Fentem, Ingrid Gerner, Alessandro Giuliani, Tim J.B. Gray, David J. Livingstone, W. McLean Provan, Fons A.J.J.L. Rutten, Henk J.M. Verhaar & Peter Zbinden. (2020) The Integrated Use of Alternative Approaches for Predicting Toxic Hazard. Alternatives to Laboratory Animals 23:3, pages 410-429.
Crossref
Laurence S. Kaminsky. 1990. Toxic Interactions. Toxic Interactions
207
231
.
J.S. Jenkins, C.P. Valcke & D.S. Ward. (1989) An extended soluble gas exchange model for estimating pulmonary perfusion. I. Derivation and implementation. IEEE Transactions on Biomedical Engineering 36:11, pages 1098-1104.
Crossref
Dennis J. Paustenbach, Harvey J. ClewellIIIIII, Michael L. Gargas & Melvin E. Andersen. (1988) A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. Toxicology and Applied Pharmacology 96:2, pages 191-211.
Crossref
R. H. Reitz, J. C. Ramsey, M. E. Andersen & P. J. Gehring. 1988. Carcinogenicity. Carcinogenicity
55
64
.
Alice M. Wyrwicz, Claire B. Conboy, Brenda G. Nichols, Kenneth R. Ryback & Pamela Eisele. (1987) In vivo 19F-NMR study of halothane distribution in brain. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 929:3, pages 271-277.
Crossref
Peter Veng-Pedersen. (1984) Pulmonary Absorption and Excretion of Compounds in the Gas Phase: Theoretical Pharmacokinetic and Toxicokinetic Analysis. Journal of Pharmaceutical Sciences 73:8, pages 1136-1141.
Crossref
John C. Ramsey & Melvin E. Andersen. (1984) A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73:1, pages 159-175.
Crossref
George M. MaxwellGeorge M. Maxwell. 1983. Principles of Paediatric Pharmacology. Principles of Paediatric Pharmacology
101
150
.
W. Beuter & A. Schmid. 1983. Veterinary Pharmacology and Toxicology. Veterinary Pharmacology and Toxicology
479
484
.
Christopher Walsh. 1983. Advances in Enzymology and Related Areas of Molecular Biology. Advances in Enzymology and Related Areas of Molecular Biology
197
289
.
V. Fiserova-Bergerova. 1981. Industrial and Environmental Xenobiotics. Industrial and Environmental Xenobiotics
211
220
.